Cargando…
Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse
Differentiation of active disease from fibrosis/mature teratoma in patients with residual masses or identifying of sites of recurrence in patients with raised markers following treatment of their testicular cancer remains a problem.(18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) has...
Autores principales: | Hain, S F, O’Doherty, M J, Timothy, A R, Leslie, M D, Harper, P G, Huddart, R A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374687/ https://www.ncbi.nlm.nih.gov/pubmed/10970686 http://dx.doi.org/10.1054/bjoc.2000.1389 |
Ejemplares similares
-
Thoracic positron emission tomography: (18)F-fluorodeoxyglucose and beyond
por: Jaykel, Timothy J., et al.
Publicado: (2020) -
[(18)F]fluorodeoxyglucose positron emission tomography/computed tomography characteristics of primary mediastinal germ cell tumors
por: Lee, Koeun, et al.
Publicado: (2023) -
18-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography to Guide Aortic Arch Replacement in Relapsing Polychondritis
por: Pfister, Raymond, et al.
Publicado: (2019) -
Tumour response evaluation with fluorodeoxyglucose positron emission tomography: research technique or clinical tool?
por: Anderson, H., et al.
Publicado: (2010) -
Fluorodeoxyglucose-positron emission tomography in carcinoma nasopharynx: Can we predict outcomes and tailor therapy based on postradiotherapy fluorodeoxyglucose-positron emission tomography?
por: Laskar, Sarbani Ghosh, et al.
Publicado: (2016)